Literature DB >> 8688328

Abnormal expression of integrin alpha 6 beta 4 in cervical intraepithelial neoplasia.

J D Aplin1, S Dawson, M W Seif.   

Abstract

We have used subunit-specific monoclonal antibodies (MAbs) and immunohistochemistry to examine the distribution of integrin alpha 6 beta 4 in normal ectocervical epithelium and various grades of cervical intraepithelial neoplasia (CIN). Antibodies were first characterised by immunoprecipitation from two surface-labelled tumour cell lines. Monoclonal antibody G71 was found to precipitate integrin beta 4 from BeWo but not T47D cells, while other anti-beta 4 antibodies precipitated beta 4 from both cell lines. Both G71 and an antiserum to the C-terminal peptide of beta 4 precipitated free beta 4 from surface-iodinated BeWo cells. Neither antibody recognised truncated beta 4 chains observed at approximately 160 kDa. These data suggest that different isoforms of beta 4 are expressed in different tumour cell lines, and that there may be a pool of beta 4 at the cell surface that is not complexed to alpha 6. In normal cervix, both the alpha 6 and beta 4 subunits occur at the basal surface of the basal cell layer. In CIN, the distribution is markedly altered, with strong expression of alpha 6 and beta 4 in the upper cell layers of the ectocervical epithelium. All 40 cases of CIN that were studied exhibited this alteration. Furthermore, the extent of extrabasal staining appeared to correspond with the grade of CIN. The form of integrin beta 4 recognised by antibody G71 also appears in the upper cell layers in CIN, but it shows a more restricted distribution than the normal isoform.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8688328      PMCID: PMC2074567          DOI: 10.1038/bjc.1996.344

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

1.  Changes in integrin receptors on oncogenically transformed cells.

Authors:  L C Plantefaber; R O Hynes
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

2.  Basally located epithelial cell surface component identified by a novel monoclonal antibody technique.

Authors:  J D Aplin; M W Seif
Journal:  Exp Cell Res       Date:  1985-10       Impact factor: 3.905

3.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

4.  Monoclonal antibody to human carcinoma-associated protein complex: quantitation in normal and tumor tissue.

Authors:  R Falcioni; A Sacchi; J Resau; S J Kennel
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

5.  Analysis of the tumor-associated antigen TSP-180. Identity with alpha 6-beta 4 in the integrin superfamily.

Authors:  S J Kennel; L J Foote; R Falcioni; A Sonnenberg; C D Stringer; C Crouse; M E Hemler
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

6.  An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers. Application to immunoperoxidase studies on eosinophil-rich tissue preparations.

Authors:  S M Andrew; B Jasani
Journal:  Histochem J       Date:  1987-08

7.  Abnormal expression of G71 antibody at the epidermal basement membrane in basal cell carcinoma.

Authors:  M J Tidman; J D Aplin; D M MacDonald
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860

8.  Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.

Authors:  G H Anderson; D A Boyes; J L Benedet; J C Le Riche; J P Matisic; K C Suen; A J Worth; A Millner; O M Bennett
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

9.  Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kd cytoplasmic domain.

Authors:  F Hogervorst; I Kuikman; A E von dem Borne; A Sonnenberg
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

10.  Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells.

Authors:  S Suzuki; Y Naitoh
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more
  1 in total

Review 1.  Clinical significance of the integrin α6β4 in human malignancies.

Authors:  Rachel L Stewart; Kathleen L O'Connor
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.